Edgewise Therapeutics Inc. has granted a new non-executive employee a stock option to purchase 26,250 shares of the company's common stock at an exercise price of $26.04 per share, matching the closing price on the grant date. Under the terms, 25% of the shares will vest on the employee's one-year anniversary, with the remaining shares vesting monthly over the following three years, contingent on continued employment. This grant was made under Edgewise's 2024 Inducement Equity Incentive Plan.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edgewise Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA36658) on December 02, 2025, and is solely responsible for the information contained therein.